136 related articles for article (PubMed ID: 9584897)
1. DNA-cytometry of progressive and regressive cervical intraepithelial neoplasia.
Hanselaar AG; Poulin N; Pahlplatz MM; Garner D; MacAulay C; Matisic J; LeRiche J; Palcic B
Anal Cell Pathol; 1998; 16(1):11-27. PubMed ID: 9584897
[TBL] [Abstract][Full Text] [Related]
2. Nuclear DNA content analysis by static cytometry in cervical intraepithelial lesions using retrospective series of previously stained PAP smears.
Shirata NK; Gomes NS; Garcia EA; Longatto Filho A
Adv Clin Path; 2001 Jul; 5(3):87-91. PubMed ID: 11753880
[TBL] [Abstract][Full Text] [Related]
3. Nuclear morphometry as an intermediate endpoint biomarker in chemoprevention of cervical carcinoma using alpha-difluoromethylornithine.
Poulin N; Boiko I; MacAulay C; Boone C; Nishioka K; Hittelman W; Mitchell MF
Cytometry; 1999 Oct; 38(5):214-23. PubMed ID: 10516607
[TBL] [Abstract][Full Text] [Related]
4. [DNA-cytometry in dysplasias of the uterine cervix].
Bollmann R
Zentralbl Gynakol; 2001 Apr; 123(4):206-10. PubMed ID: 11370528
[TBL] [Abstract][Full Text] [Related]
5. [Assessment of cervical intraepithelial neoplasia (CIN) lesions by DNA image cytometry].
Sun XR; Che DY; Tu HZ; Li D; Wang J
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):831-5. PubMed ID: 17416004
[TBL] [Abstract][Full Text] [Related]
6. Applicability of liquid-based cytology to the assessment of DNA content in cervical lesions using static cytometry.
Shirata NK; Longatto Filho A; Roteli-Martins C; Espoladore LM; Pittoli JE; Syrjänen K
Anal Quant Cytol Histol; 2003 Aug; 25(4):210-4. PubMed ID: 12961827
[TBL] [Abstract][Full Text] [Related]
7. [Diagnostic and prognostic use of DNA-Image-Cytometry in cervical squamous intraepithelial lesions and invasive carcinoma].
Sun XR; Wang J; Boecking A
Zhonghua Bing Li Xue Za Zhi; 2005 Jul; 34(7):435-7. PubMed ID: 16251055
[No Abstract] [Full Text] [Related]
8. Role of FoxP3-positive regulatory T-cells in regressive and progressive cervical dysplasia.
Vattai A; Kremer N; Meister S; Beyer S; Keilmann L; Hester A; Temelkov M; Heidegger H; Schmoeckel E; Kessler M; Mahner S; Jeschke U; Hertlein L; Kolben T
J Cancer Res Clin Oncol; 2022 Feb; 148(2):377-386. PubMed ID: 34739585
[TBL] [Abstract][Full Text] [Related]
9. Diagnostic and prognostic use of DNA image cytometry in cervical squamous intraepithelial lesions and invasive carcinoma.
Böcking A; Nguyen VQ
Cancer; 2004 Feb; 102(1):41-54. PubMed ID: 14968417
[TBL] [Abstract][Full Text] [Related]
10. Predictive value of DNA cytometry in CIN 1 and 2. Image analysis of 193 cases.
Hering B; Horn LC; Nenning H; Kühndel K
Anal Quant Cytol Histol; 2000 Aug; 22(4):333-7. PubMed ID: 10965410
[TBL] [Abstract][Full Text] [Related]
11. DNA cytometry confirms the utility of the Bethesda system for the classification of Papanicolaou smears.
Bollmann R; Bollmann M; Henson DE; Bodo M
Cancer; 2001 Jun; 93(3):222-8. PubMed ID: 11391611
[TBL] [Abstract][Full Text] [Related]
12. Identification of progressive cervical epithelial cell abnormalities using DNA image cytometry.
Grote HJ; Nguyen HV; Leick AG; Böcking A
Cancer; 2004 Dec; 102(6):373-9. PubMed ID: 15526273
[TBL] [Abstract][Full Text] [Related]
13. Human papillomavirus infection, centrosome aberration, and genetic stability in cervical lesions.
Skyldberg B; Fujioka K; Hellström AC; Sylvén L; Moberger B; Auer G
Mod Pathol; 2001 Apr; 14(4):279-84. PubMed ID: 11301343
[TBL] [Abstract][Full Text] [Related]
14. DNA changes in progressive cervical intraepithelial neoplasia.
Hanselaar AG; Vooijs GP; Mayall BH; Pahlplatz MM; Van't Hof-Grootenboer AE
Anal Cell Pathol; 1992 Jul; 4(4):315-24. PubMed ID: 1390300
[TBL] [Abstract][Full Text] [Related]
15. Feulgen staining remains the gold standard for precise DNA image cytometry.
Biesterfeld S; Beckers S; Del Carmen Villa Cadenas M; Schramm M
Anticancer Res; 2011 Jan; 31(1):53-8. PubMed ID: 21273580
[TBL] [Abstract][Full Text] [Related]
16. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
Liao SY; Stanbridge EJ
Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
[TBL] [Abstract][Full Text] [Related]
17. Relation of quantitative features of visually normal intermediate cells in cervical intraepithelial neoplasia I and II smears to progression or nonprogression of the lesion.
Kwikkel HJ; Timmers T; Boon ME; van Rijswijk MM; Stolk JG
Anal Quant Cytol Histol; 1987 Oct; 9(5):405-10. PubMed ID: 3675799
[TBL] [Abstract][Full Text] [Related]
18. [Assessment of cervical dysplasia with DNA image cytometry].
Böcking A; Motherby H
Pathologe; 1999 Jan; 20(1):25-33. PubMed ID: 10091229
[TBL] [Abstract][Full Text] [Related]
19. Cytometric evidence that cervical intraepithelial neoplasia I and II are dysplasias rather than true neoplasias. An image analysis study of factors involved in the progression of cervical lesions.
Mariuzzi G; Santinelli A; Valli M; Sisti S; Montironi R; Mariuzzi L; Alberti R; Pisani E
Anal Quant Cytol Histol; 1992 Apr; 14(2):137-47. PubMed ID: 1590897
[TBL] [Abstract][Full Text] [Related]
20. Microinvasive cervical carcinoma and cervical intraepithelial neoplasia: biologic significance and clinical implications of 72-kDa metalloproteinase immunostaining.
Garzetti GG; Ciavattini A; Lucarini G; Goteri G; De Nictolis M; Biagini G
Gynecol Oncol; 1996 May; 61(2):197-203. PubMed ID: 8626132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
